Physician

Michael Martin Hatch, M.D.

According to 2025 Medicare claims, Michael Hatch, M.D. (NPI: 1831551092) practices dermatology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY PA (NPI: 1043615263; TIN: 47-2190514) and primary practice location at 76710-7029.

Hatch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,662 traditional Medicare patients, billed 13,240 HCPCS/CPT codes, and received $671,685 in Medicare payments. The top billing code was 88312 (Special stained specimen slides to identify organisms including interpretation and report). Part D data shows 730 prescription claims across 238 beneficiaries totaling $313,499 in drug costs, led by Tacrolimus (Tacrolimus). Open Payments data shows 27 records totaling $447. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $661 to $313,499. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$336K$672K2021 Medicare payment: $167,948 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $505,938 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $643,056 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $671,685 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211,6982,888$167,948
20225,2529,201$505,938
20236,60012,200$643,056
20246,66213,240$671,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$157K$313K2016 Drug cost: $661 (USD; Tot_Drug_Cst)2017 Drug cost: $19,243 (USD; Tot_Drug_Cst)2018 Drug cost: $57,176 (USD; Tot_Drug_Cst)2019 Drug cost: $77,778 (USD; Tot_Drug_Cst)2020 Drug cost: $99,641 (USD; Tot_Drug_Cst)2021 Drug cost: $2,794 (USD; Tot_Drug_Cst)2022 Drug cost: $9,321 (USD; Tot_Drug_Cst)2023 Drug cost: $67,082 (USD; Tot_Drug_Cst)2024 Drug cost: $313,499 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161526$661
2017111241$19,243
2018170478$57,176
2019147368$77,778
2020109318$99,641
20213257$2,794
2022105252$9,321
2023170462$67,082
2024238730$313,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88312Special stained specimen slides to identify organisms including interpretation and report327391$79
88342Special stained specimen slides to examine tissue, initial procedure555589$76
88341Special stained specimen slides to examine tissue, each additional procedure286426$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more322423$57
88305Pathology examination of tissue using a microscope, intermediate complexity6,0788,889$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TacrolimusTacrolimus26790$3,927
Clobetasol PropionateClobetasol Propionate842,492$2,614
FluorouracilFluorouracil27784$1,682
Mycophenolate MofetilMycophenolate Mofetil14660$1,634
Triamcinolone AcetonideTriamcinolone Acetonide1083,130$1,351

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$447Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Martin Hatch, M.D.?

Tedicare shows public-source Medicare data for Michael Martin Hatch, M.D. (NPI 1831551092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Martin Hatch, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Martin Hatch, M.D.?

Michael Martin Hatch, M.D. is linked to EPIPHANY DERMATOLOGY PA (billing NPI 1043615263) in the available physician profile data.

Does Michael Martin Hatch, M.D. have Open Payments data?

Michael Martin Hatch, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.